Cancer will affect millions of people every year. Thanks to one genetics expert, researchers are working towards effective treatments for many deadly cancers. Seattle Genetics’ Clay Siegall stands at the forefront of the battle using his expertise in the field of genetics.
About 40 percent of people, in the United States, will be diagnosed with some form of cancer at some point in their life, according to the National Cancer Institute. Many cancers are triggered when certain genes malfunction and begin to produce cells in an out-of-control manner. Cancer treatments usually involve dangerous chemotherapies that can cause mortal side effects. Gene therapy, however, can zero in on the malfunction genes and correct them.
This is where Dr. Clay Siegall’s expertise comes into play. As the leader of Seattle Genetics, Dr. Siegall is leading important research in the field of gene therapy. Thanks to some recent breakthroughs in whole gene sequencing, it has become easier for researchers and doctors to develop cancer treatments. In fact, the diagnosis and treatment of most cancers can improve in two-thirds of the cases thanks to whole gene sequencing.
Seattle Genetics is currently using the breakthroughs in gene sequencing to create gene therapies which target specific kinds of cancers. The result is that patients are now less likely to have to deal with chemotherapy. Furthermore, these types of therapies mean less hospital time for the patient, a higher tumor remission rate and, most importantly, a longer survival rate for millions of patients.
Dr. Clay Siegall holds several degrees including a Bachelor of Science in Zoology from The University Of Maryland and a Doctorate in Genetics from George Washington University. Dr. Siegall founded Seattle Genetics in 1998. In the nearly two decades since its founding, Seattle Genetics has become the leader in targeted gene therapies.
Currently, Dr. Clay Siegall is overseeing a crowded pipeline of therapies being developed by Seattle Genetics. And these therapies are expected to hit the market in several years. With a passion to save millions of lives, Dr. Clay Siegall is driving Seattle Genetics to further breakthroughs in the fight against cancer.